Articles

Nvidia’s stock heads for biggest drop in over a year and biggest market-cap loss ever

Nvidia is about to report another set of blowout results Wednesday, but Wall Street has come to expect that from the chip giant.

AI stocks in the S&P 500 have outperformed this year — and not just the ‘Magnificent Seven’

It’s not just the top seven companies in the S&P 500 that are benefiting from the stock-market craze around artificial intelligence, according to Bespoke Investment Group.

I have $1.5 million in stocks and bonds. I asked my broker to convert my bonds to cash. He didn’t and my portfolio fell by $100,000. Can I sue?

“I also suggested that the company liquidate some growth stocks and either keep the proceeds in cash or invest it in value stocks.”

Traders are flirting with the idea of a Fed rate hike as January meeting minutes loom

It’s taken months to sink in, but traders are finally coming around to the once-unthinkable scenario of possibly no rate cuts in 2024 and are now even considering the idea of another hike by the U.S. central bank.

U.S. stocks could fall in March thanks to waning momentum, ‘seasonal’ weakness: analyst

The recent bullish momentum that has propelled U.S stocks to record territory is fading, and “seasonal” weakness in March could push major stock indexes into one of their worst stretches of the year, according to Jonathan Krinsky, chief market technician at BTIG.

‘Most people do not have a plan’: Think you’re ready to retire? You might not be worried enough.

Perceptions about retirement often don’t match up with reality.

3 ways a ‘Magnificent Seven’ stock-market bubble could burst

If the megacap tech rally is indeed a bubble, how might it end?

Has it become easier to beat index funds?

The growth of indexing may lead to some stocks being overvalued while others may be undervalued

Meta, Google and other social-media companies brace for heightened deepfake perils ahead of 2024 elections

“The capacity for individuals and nation-states to generate more misleading content that is microtargeted and harder to detect could happen.”

AbbVie taps new CEO as it faces fresh competition for blockbuster drug Humira

AbbVie’s founding CEO Richard Gonzalez will step down July 1, the drugmaker said Tuesday.

I’m a 42-year-old father with a $210,000 investment property. Can I leave it to my daughter without triggering a large capital-gains tax?

‘‘I bought the property for $120,000 and it’s currently valued at $210,000. My daughter says that she wants this home to be her first home.”

Recession signs fade despite 22nd straight drop in Leading Economic Index

The leading indicators of the economy fell in January for the 22nd month in a row — the third longest losing streak ever — but the U.S. still doesn’t appear to be careening toward a recession.
1 1,008 1,009 1,010 1,011 1,012 1,879